Abstract
Various gene expression DNA microarray platforms have been developed and often similar experiments are conducted using different types of arrays. Several investigators have explored the cross-platform comparison issues and reached mixed conclusions, ranging from discrepant to reasonably concordant results across platforms. These comparative studies, however, did not apply rigorous sequence-matching criteria. Since the sample size in each experiment is small, combining the information may help increase statistical power. Here we address this issue using the probe sequences to determine matching probes. Smooth muscle cells from the thoracic aorta of C57B46J mice treated with benzo(a)pyrene or dimethyl sulfoxide were examined using GeneChip and CodeLink arrays. Corresponding probes on the two platforms were identified by stand-alone BLAST. In general, CodeLink selected more genes as differentially expressed. For GeneChip arrays, among the various algorithms considered, more probe sets were found significantly changed using the MAS 5.0 expression estimates. The Li-Wong PM-only expression estimates led to fewer discordant results between the two platforms. We conducted quantitative RT-PCR assays on several genes to further assess the performance of each platform. We found that the use of different expression estimation algorithms led to different results within the same platform. The qRT-PCR experiments did not consistently confirm the results of either platform.
Keywords: Aorta smooth muscle cells, CodeLink, GeneChip, platform comparison
Current Bioinformatics
Title: Comparison of High-Density Short Oligonucleotide Microarray Platforms
Volume: 2 Issue: 3
Author(s): Mahlet G. Tadesse, Qiang He, Raymond J. Carroll and Kenneth S. Ramos
Affiliation:
Keywords: Aorta smooth muscle cells, CodeLink, GeneChip, platform comparison
Abstract: Various gene expression DNA microarray platforms have been developed and often similar experiments are conducted using different types of arrays. Several investigators have explored the cross-platform comparison issues and reached mixed conclusions, ranging from discrepant to reasonably concordant results across platforms. These comparative studies, however, did not apply rigorous sequence-matching criteria. Since the sample size in each experiment is small, combining the information may help increase statistical power. Here we address this issue using the probe sequences to determine matching probes. Smooth muscle cells from the thoracic aorta of C57B46J mice treated with benzo(a)pyrene or dimethyl sulfoxide were examined using GeneChip and CodeLink arrays. Corresponding probes on the two platforms were identified by stand-alone BLAST. In general, CodeLink selected more genes as differentially expressed. For GeneChip arrays, among the various algorithms considered, more probe sets were found significantly changed using the MAS 5.0 expression estimates. The Li-Wong PM-only expression estimates led to fewer discordant results between the two platforms. We conducted quantitative RT-PCR assays on several genes to further assess the performance of each platform. We found that the use of different expression estimation algorithms led to different results within the same platform. The qRT-PCR experiments did not consistently confirm the results of either platform.
Export Options
About this article
Cite this article as:
Tadesse G. Mahlet, He Qiang, Carroll J. Raymond and Ramos S. Kenneth, Comparison of High-Density Short Oligonucleotide Microarray Platforms, Current Bioinformatics 2007; 2(3) . https://dx.doi.org/10.2174/157489307781662132
DOI https://dx.doi.org/10.2174/157489307781662132 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
To Cardiovascular Disease and Beyond: New Therapeutic Perspectives of Statins in Autoimmune Diseases and Cancer
Current Drug Targets Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Current Cancer Drug Targets An Investigative Approach to Treatment Modalities for Squamous Cell Carcinoma of Skin
Current Drug Delivery Bone Modulating Bioactive Natural Compounds: Review
Current Bioactive Compounds Effects of Surface Morphology Variation on the Degradation Rate of Poly(L-Lactic Acid) Membranes and the Behavior of Attached Cells
Micro and Nanosystems Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design Last Generation of Amino-Bisphosphonates (N-BPs) and Cancer Angiogenesis: A New Role for These Drugs?
Recent Patents on Anti-Cancer Drug Discovery Novel Polymer-Ceramics for Bone Repair and Regeneration
Recent Patents on Biomedical Engineering (Discontinued) Momordicacharantia: A New Strategic Vision to Improve the Therapy of Endoplasmic Reticulum Stress
Current Pharmaceutical Design Application of Baculovirus-Insect Cell Expression System for Human Therapy
Current Pharmaceutical Biotechnology Anti-Angiogenic Therapies for Children with Cancer
Current Cancer Drug Targets Pharmacologic Ovarian Preservation in Young Women Undergoing Chemotherapy
Current Medicinal Chemistry Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy
Current Cancer Drug Targets The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy
Current Drug Targets Mesenchymal Stem Cells and Their Cell Surface Receptors
Current Rheumatology Reviews Chemosensitization by Antisense Oligonucleotides Targeting MDM2
Current Cancer Drug Targets Double Point Modified Analogs of Vitamin D as Potent Activators of Vitamin D Receptor
Current Pharmaceutical Design Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Gene Therapy of Endometriosis
Recent Patents on DNA & Gene Sequences